The role of tumor necrosis factor and nitric oxide in the acute cardiovascular response to endotoxin

Annals of Surgery

Volumn 223, Issue 1, 1996, Pages 63-69

  Fahey III, Thomas J ^a   Yoshioka, Tomoki ^a   Shires, G Tom ^a   Fantini, Gary A ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; NITRIC OXIDE; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN ANTIBODY COMPLEX; ARTERIAL PRESSURE; ARTICLE; CARDIOGENIC SHOCK; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; ENDOTOXEMIA; NONHUMAN; PRIORITY JOURNAL; RAT; REPRODUCIBILITY; SEPTIC SHOCK;

ANIMALS; ARGININE; CARDIOVASCULAR DISEASES; ENDOTOXINS; ENZYME INHIBITORS; HEMODYNAMIC PROCESSES; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RATS; RATS, SPRAGUE-DAWLEY; SHOCK, SEPTIC; TOXEMIA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030048260     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-199601000-00009     Document Type: Article

References (22)

1. Tracey KJ, Fong Y, Hesse DG, et al. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 1987; 330:662-664.
2. Okusawa S, Gelfand JA, Ikejima T, et al. Interleukin-1 induces a shock-like stat in rabbits: synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. J Clin Invest 1988; 81:1162-1172.
3. Jacobs ER, Soulsby ME, Bone RC, et al. Ibuprofen in canine endotoxin shock. J Clin Invest 1982; 70:536-541.
4. Anderson BO, Bensard DD, Alden HH. The role of platelet activating factor and its antagonists in shock, sepsis and multiple organ failure. Surg Gynecol Obstet 1991; 172(5):415-424.
5. G-methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem Biophys Res Commun 1990; 172(3):1132-1138.
6. Thiemermann C, Vane J. Inhibition of nitric oxide synthesis re- duces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo. Eur J Pharm 1990; 182:591-595.
7. G-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for involvement of nitric oxide. Proc Natl Acad Sci 1990; 87:3629-3632.
8. Fahey TJ III, Sherry B, Tracey KJ, et al. Cytokine production in a model of wound healing: the appearance of MIP-1, MIP-2, cachectin/TNF, and IL-1. Cytokine 1990; 2:92-99.
9. Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65:55-63.
10. Beutler B, Milsark IW, Cerami A. Cachectin/tumor necrosis factor. Production, distribution, and metabolic fate in vivo. J Immunol 1985; 135:3972-3977.
11. Mathison JC, Wolfson E, Ulevitch JR. Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits. J Clin Invest 1988; 81:1925-1937.
12. Thiermann C, Wu CC, Szabo C, et al. Role of tumour necrosis factor in the induction of nitric oxide synthase in a rat model of endotoxin shock. Br J Pharm 1993; 110:177-182.
13. Shibano T, Vanhoutte PM. Induction of NO production by TNF-α and lipopolysaccharide in porcine coronary arteries without endothelium. Am J Physiol 1993; 264:H403-H407.
14. Salvemini D, Korbut R, Angaard E, et al. Lipopolysaccharide increases release of a nitric oxide-like factor from endothelial cells. Eur J Pharm 1989; 171:135-136.
15. Pagani FD, Baker LS, Knox MA, et al. Load-insensitive assessment of myocardial performance after tumor necrosis factor-α in dogs. Surgery 1992; 111(5):683-693.
16. DeMeules JE, Pigula FA, Mueller M, et al. Tumor necrosis factor and cardiac function. J Trauma 1992; 32(6):686-692.
17. Yokoyama T, Vaca L, Rossen RD, et al. Cellular basis for the negative inotropic effects of tumor necrosis factor-α in the adult mammalian heart. J Clin Invest 1993; 92:2303-2312.
18. Tracey KJ, Lowry SF, Fahey TJ III, et al. Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog. Surg Gynecol Obstet 1987; 164:415-422.
19. Bucala R, Tracey KJ, Cerami A. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilation in experimental diabetes. J Clin Invest 1991; 87(2):432-438.
20. G-methyl-L-arginine are abolished in a canine shock model using high-dose endotoxin. Res Commun Pathol Pharm 1992; 78(1):57-68.
21. Wright CE, Rees DD, Moncada S. Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res 1992; 26:48-57.
22. G-monomethyl-L-arginine. J Cardio Pharm 1992; 20(12):S132-S134.